Expanded Access Use of Ladiratuzumab Vedotin in Advanced Solid Tumors
Clinical trial NCT06362590 · AVAILABLE
Trial details
- NCT number
- NCT06362590
- Sponsor
- Seagen Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.